Technical Sales Representative
About the job
- A degree in Agronomy, Agricultural Sciences, or a related field is required.
- Experience in technical sales, agronomy, agricultural advisory, crop protection, or a related agricultural field is required.
- A strong understanding of agronomy and crop protection products is required, including the ability to demonstrate technical solutions in the field and communicate their value to customers.
- The role requires the ability to engage effectively with growers, distributors, advisors, and other industry stakeholders.
- Proficiency in Microsoft Office applications, particularly Word and Excel, is required.
- Fluency in Turkish is required; English language skills are an advantage.
- A valid driving license, willingness to travel extensively within the region and across Turkey as required, and the ability to work independently in a dynamic commercial environment are required.
- Serve as the primary FMC contact for customers within the Antalya region.
- Build and maintain strong relationships with growers, distributors, advisors, and food chain companies.
- Provide technical guidance and product recommendations based on customer needs and agronomic conditions.
- Conduct product demonstrations and organise field trials to showcase product performance and efficacy.
- Promote FMC crop protection solutions and support achievement of regional sales objectives.
- Monitor customer activity and follow up on sales, orders, and collections.
- Prepare and share regular sales and field activity reports.
- Travel within the region to support customers, conduct demonstrations, and identify business opportunities.
- Experience conducting field trials, product demonstrations, or agronomic evaluations, and knowledge of local agricultural markets or crop segments would be advantageous.
- English language skills are an advantage.
About the company
FMC develops and supplies crop protection products, including herbicides, insecticides, and fungicides, plus formulations and technologies that help protect crops from pests and diseases. Its products work by using chemical active ingredients and tailored formulations that control pests while aiming to minimize environmental impact; the company emphasizes science-driven solutions to improve efficacy and safety in farming. Compared with competitors, FMC leverages a long history (over a century) and a clear focus on sustainable technologies that protect both crops and the environment, with ongoing discovery of new actives and innovative formulations. The company’s goal is to help feed the world’s growing population by delivering effective crop protection that is better for the planet.
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
Hong Kong
Founded
1883
Get referred to FMC
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 adjusted EBITDA hit $153 million, above FMC's guidance high end.
- FMC expects $1 billion of asset-sale and financing proceeds to reduce debt by year-end.
- Management says turnaround benefits and new products should drive growth starting in 2027.
What critics are saying
- Q2 2026 revenue fell 17% to $867 million, signaling weak demand.
- FMC posted a $186.6 million Q2 net loss and $226.6 million restructuring charges.
- Debt remains $4.4 billion, forcing covenant relief and asset sales to avoid refinancing stress.
What makes FMC unique
- FMC's R&D pipeline targets lepidopteran pests through RNA-based biomolecules with AgroSpheres.
- Rimisoxafen reached first global EPA submission on July 8, 2026.
- FMC keeps Stine Research Center as its global R&D headquarters after Tessenderlo's investment.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Professional Development Budget
Family Planning Benefits
Mental Health Support
Company News
Tessenderlo Group has completed a minority equity investment in FMC Corporation, purchasing approximately 30.3 million shares at $13.30 per share for around $403 million. The Belgian industrial group now owns roughly 20% of the US agricultural sciences company's outstanding common stock. The transaction, first announced on 30 June 2026, received all necessary regulatory approvals. As part of the deal, Tessenderlo Group has the right to nominate one independent director to FMC's board and has put forward its chief executive officer, Luc Tack. Tessenderlo Group is subject to customary standstill restrictions and a three-year lock-up period on its shares. FMC develops crop protection solutions including biologicals and precision agriculture technologies. Tessenderlo Group, which operates in over 100 countries, recorded consolidated revenue of €2.8 billion in 2025.
FMC Corporation reported second quarter 2026 revenue of $867 million, down 17% year-over-year, with adjusted EBITDA of $153 million exceeding guidance. Excluding India, revenue fell 20% to $841 million, with organic revenue declining 22%. The company posted a GAAP net loss of $187 million, or $1.49 per diluted share. Adjusted earnings per share reached $0.26, down 62% from the prior year. Cash from operations rose significantly to $363 million, up $297 million year-over-year. FMC lowered its full-year outlook due to challenging macroeconomic conditions. The company now expects revenue excluding India of $3.50 billion to $3.70 billion and adjusted EBITDA between $620 million and $680 million. Free cash flow guidance increased to $75 million to $225 million, including a $200 million upfront licensing payment for rimisoxafen.
Tessenderlo Group has agreed to invest $400 million in FMC Corporation for a 20% stake at $13.30 per share, valuing the agricultural sciences company at approximately $2 billion. The transaction concludes FMC's strategic review initiated in February 2026 and supports its $1 billion debt reduction target. The Belgian industrial group described the investment as part of its strategy to acquire cornerstone minority stakes in high-quality agricultural companies. FMC said the agreement aligns with its operational plans, including advancing its R&D pipeline and commercialising new innovations. The deal follows recent FMC initiatives including a $1.2 billion bond offering, the $252 million sale of its India business, and a $200 million prepayment from Corteva. The transaction requires regulatory approvals and customary closing conditions.
FMC Corporation, a global agricultural sciences company, has reached a definitive agreement with Belgian industrial group Tessenderlo Group for a $400 million minority equity investment at $13.30 per share. Upon completion, Tessenderlo Group will own approximately 20% of FMC's outstanding shares. The transaction concludes FMC's strategic options review announced in February 2026. FMC will use the proceeds to pay down debt, reaching its approximately $1 billion debt paydown target. Recent actions include raising $1.2 billion in secured bonds, selling its India commercial business for $252 million, and securing a $200 million prepayment from a Corteva agreement. The deal is subject to regulatory approvals. BofA Securities and Goldman Sachs advised FMC, whilst Stibbe and Sullivan & Cromwell advised Tessenderlo Group.
FMC Corporation has raised $750 million through senior secured notes due 2031, issued under Regulation S and Rule 144A with guarantees. The fixed-income offering aims to strengthen the company's financial position and provide flexibility for operations, debt management and potential growth initiatives. The financing comes alongside a sharp dividend cut announced in April 2026, from $0.58 to $0.08 per share, signalling management's focus on cash preservation and balance sheet repair. FMC faces elevated leverage and weak interest coverage, making debt management the key near-term catalyst. Whilst the bond issue may ease short-term liquidity pressure, the company's investment narrative still depends on restoring profitability and cash generation in its crop protection business. Some analysts project FMC could reach $4.5 billion in revenue and $429 million in earnings.